HIF1A and Parkinson disease: Notably, the potential value of activating HIF-1 has been highlighted in consideration of its positive and protective effects in neurodegenerative models, predicting that it might likewise interfere with pathogenesis of idiopathic PD and ameliorate the clinical outcomes of PD patients [40].